17-28365177-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001080837.4(SEBOX):c.-26C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,611,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000089 ( 0 hom. )
Consequence
SEBOX
NM_001080837.4 5_prime_UTR_premature_start_codon_gain
NM_001080837.4 5_prime_UTR_premature_start_codon_gain
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.812
Genes affected
SEBOX (HGNC:32942): (SEBOX homeobox) Homeodomain proteins, such as SEBOX, play a key role in coordinating gene expression during development (Cinquanta et al., 2000 [PubMed 10922053]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEBOX | NM_001080837.4 | c.-26C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/3 | ENST00000536498.6 | NP_001074306.3 | ||
SEBOX | NM_001080837.4 | c.-26C>T | 5_prime_UTR_variant | 1/3 | ENST00000536498.6 | NP_001074306.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEBOX | ENST00000536498.6 | c.-26C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/3 | 5 | NM_001080837.4 | ENSP00000444503.3 | |||
SEBOX | ENST00000536498.6 | c.-26C>T | 5_prime_UTR_variant | 1/3 | 5 | NM_001080837.4 | ENSP00000444503.3 | |||
ENSG00000273171 | ENST00000555059.2 | c.330-222C>T | intron_variant | 4 | ENSP00000452347.3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152130Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000206 AC: 5AN: 242176Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131580
GnomAD3 exomes
AF:
AC:
5
AN:
242176
Hom.:
AF XY:
AC XY:
2
AN XY:
131580
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1459630Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 725848
GnomAD4 exome
AF:
AC:
13
AN:
1459630
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
725848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74302
GnomAD4 genome
AF:
AC:
13
AN:
152130
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74302
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2023 | The c.53C>T (p.S18F) alteration is located in exon 1 (coding exon 1) of the SEBOX gene. This alteration results from a C to T substitution at nucleotide position 53, causing the serine (S) at amino acid position 18 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at